Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Comera Life Sciences Holdings, Inc. (CMRA) had Return on Tangible Equity of 1041.07% for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$0.63M |
|
$-18.38M |
|
$0.21M |
|
$0.42M |
|
$12.60M |
|
$-11.97M |
|
$-6.03M |
|
$-18.00M |
|
$-18.00M |
|
$-18.00M |
|
$-18.00M |
|
$-18.00M |
|
$-18.00M |
|
$-11.97M |
|
$-11.88M |
|
10.45M |
|
10.45M |
|
$-1.76 |
|
$-1.76 |
|
| Balance Sheet Financials | |
$3.06M |
|
$0.26M |
|
$0.66M |
|
$3.73M |
|
$5.06M |
|
-- |
|
$0.40M |
|
$5.46M |
|
$-6.25M |
|
$-1.73M |
|
$-1.73M |
|
16.71M |
|
| Cash Flow Statement Financials | |
$-9.77M |
|
$-0.03M |
|
$5.24M |
|
$6.56M |
|
$2.00M |
|
$-4.56M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
66.77% |
|
-1890.69% |
|
-1890.69% |
|
-1875.85% |
|
-2843.79% |
|
-2902.84% |
|
$-9.80M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
-- |
|
18.45 |
|
19.79 |
|
288.20% |
|
|
Return on Tangible Equity |
1041.07% |
-483.06% |
|
1041.07% |
|
$-0.10 |
|
$-0.94 |
|
$-0.93 |
|